Novavax (NASDAQ:NVAX) has agreed to settle a securities class action over its COVID-19 vaccine claims for $47M. The lawsuit was filed in 2021 by Sothinathan Sinnathurai in the U.S. District Court of ...
Chikungunya is an “emerging global health threat,” per the FDA, and at least 5 million cases have been reported since 2008.
The world's first vaccine to protect against chikungunya virus, which is spread by mosquitoes, was just approved by the U.S. Food and Drug Administration (FDA). "Infection with chikungunya virus ...
The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults ...
FRIDAY, Nov. 10, 2023 (Healthday News) -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot ...
The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites.
The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva Austria's parent company is France's Valneva SE.
Nov. 10, 2023 -- The FDA on Thursday approved the first vaccine for the chikungunya virus, which is transmitted to humans through mosquito bites. The vaccine, called Ixchiq and produced by Valneva ...
A first of its kind vaccine has been approved by the FDA to prevent infections with the chikungunya virus. The virus is most prevalent in semi-tropical and tropical areas, such as Central and ...
Valneva (NASDAQ:VALN) announced on Friday its Ixchiq single-dose, live-attenuated vaccine against the chikungunya virus was approved by the U.S. FDA. Ixchiq is the world's first vaccine against ...
Nov 10 (Reuters) - French drugmaker Valneva said on Friday the U.S. Food and Drug Administration (FDA) has approved its Chikungunya single-dose vaccine in individuals aged 18 and above. The ...
The U.S Food and Drug Administration approved the first chikungunya vaccine- Ixchiq Ixchiq is administered as a single dose intra-muscularly for individuals over 18 years of age and older who are ...
